SSI INVESTMENT MANAGEMENT LLC - BIOMARIN PHARMACEUTICAL INC ownership

Quarter-by-quarter ownership
SSI INVESTMENT MANAGEMENT LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2020$1,603,000
+31.0%
1,220,000
+5.6%
0.14%
+29.6%
Q1 2020$1,224,000
+107.8%
1,155,000
+112.7%
0.11%
+176.9%
Q4 2019$589,000
-45.0%
543,000
-47.8%
0.04%
-50.0%
Q3 2019$1,071,000
-8.3%
1,040,000
-0.1%
0.08%
-10.3%
Q2 2019$1,168,000
-42.8%
1,041,000
-42.1%
0.09%
-49.1%
Q1 2019$2,042,000
-0.0%
1,798,000
-2.0%
0.17%
-10.5%
Q4 2018$2,043,000
-5.3%
1,835,000
+2.1%
0.19%
+15.1%
Q3 2018$2,157,000
+117.2%
1,797,000
+114.2%
0.17%
+104.9%
Q2 2018$993,000
+17.5%
839,000
+10.0%
0.08%
+17.4%
Q1 2018$845,000
-61.1%
763,000
-58.4%
0.07%
-61.9%
Q4 2017$2,174,000
+5.3%
1,836,000
+6.5%
0.18%
+2.8%
Q3 2017$2,064,000
-46.3%
1,724,000
-46.7%
0.18%
-48.1%
Q2 2017$3,846,000
+9.5%
3,233,000
+8.7%
0.34%
+5.3%
Q1 2017$3,511,000
+1.9%
2,974,000
+1.2%
0.32%
+2.2%
Q4 2016$3,444,000
-2.6%
2,938,000
+3.5%
0.32%
+0.6%
Q3 2016$3,537,000
+48.1%
2,838,000
+37.3%
0.31%
+36.7%
Q2 2016$2,389,000
-4.8%
2,067,000
-2.4%
0.23%
-10.9%
Q1 2016$2,509,000
-3.8%
2,118,000
+8.5%
0.26%
-3.7%
Q4 2015$2,607,000
-38.0%
1,952,000
-37.5%
0.27%
-40.9%
Q3 2015$4,202,000
-15.6%
3,124,000
-0.0%
0.45%
-7.4%
Q2 2015$4,979,000
+2.8%
3,125,000
-2.9%
0.49%
+6.8%
Q1 2015$4,844,000
+27.4%
3,219,000
+3.0%
0.46%
+18.4%
Q4 2014$3,801,000
+11.4%
3,124,000
+0.2%
0.39%
+15.9%
Q3 2014$3,413,000
+6.7%
3,118,000
+2.6%
0.33%
+7.4%
Q2 2014$3,198,000
-2.2%
3,039,000
+3.1%
0.31%
-7.2%
Q1 2014$3,269,000
+5.3%
2,948,000
+2.1%
0.33%
+21.5%
Q4 2013$3,103,0002,887,0000.28%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 6,195,000$9,377,0002.84%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,000,000$10,750,0001.09%
Man Investments (CH) AG 1,100,000$1,482,0000.73%
ADVENT CAPITAL MANAGEMENT /DE/ 22,554,000$30,444,0000.47%
SSI INVESTMENT MANAGEMENT LLC 3,124,000$4,202,0000.45%
ARROWGRASS CAPITAL PARTNERS (US) LP 20,000$22,373,0000.42%
Calamos Advisors LLC 35,219,000$47,628,0000.33%
LINDEN ADVISORS LP 2,500,000$3,370,0000.23%
Calamos Wealth Management LLC 513,000$694,0000.17%
LOOMIS SAYLES & CO L P 477,810$50,323,0000.15%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders